Stocks and Investing Stocks and Investing
Fri, November 16, 2018
Thu, November 15, 2018
Wed, November 14, 2018
Tue, November 13, 2018
Mon, November 12, 2018
Fri, November 9, 2018
Thu, November 8, 2018
Wed, November 7, 2018
Tue, November 6, 2018

David Toung Maintained (ABBV) at Strong Buy with Decreased Target to $115 on, Nov 6th, 2018


Published on 2024-10-26 10:26:33 - WOPRAI, David Toung
  Print publication without navigation


David Toung of Argus Research, Maintained "AbbVie Inc." (ABBV) at Strong Buy with Decreased Target from $130 to $115 on, Nov 6th, 2018.

David has made no other calls on ABBV in the last 4 months.



There are 2 other peers that have a rating on ABBV. Out of the 2 peers that are also analyzing ABBV, 0 agree with David's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with David


  • Alex Arfaei of "BMO Capital" Maintained at Sell with Decreased Target to $71 on, Monday, November 5th, 2018
  • Jason Gerberry of "B of A Securities" Maintained at Strong Buy with Decreased Target to $106 on, Thursday, October 4th, 2018